Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration.

Burton ME, Ash CL, Hill DP Jr, Handy T, Shepherd MD, Vasko MR.

Clin Pharmacol Ther. 1991 Jun;49(6):685-94.

PMID:
1905602
[PubMed - indexed for MEDLINE]
2.

Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy.

Leehey DJ, Braun BI, Tholl DA, Chung LS, Gross CA, Roback JA, Lentino JR.

J Am Soc Nephrol. 1993 Jul;4(1):81-90.

PMID:
8400072
[PubMed - indexed for MEDLINE]
Free Article
3.

Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization.

Crist KD, Nahata MC, Ety J.

Ther Drug Monit. 1987 Sep;9(3):306-10.

PMID:
3672575
[PubMed - indexed for MEDLINE]
4.

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.

van Lent-Evers NA, Mathôt RA, Geus WP, van Hout BA, Vinks AA.

Ther Drug Monit. 1999 Feb;21(1):63-73.

PMID:
10051056
[PubMed - indexed for MEDLINE]
5.

Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.

Langhendries JP, Battisti O, Bertrand JM, François A, Kalenga M, Darimont J, Scalais E, Wallemacq P.

Biol Neonate. 1998 Nov;74(5):351-62.

PMID:
9742264
[PubMed - indexed for MEDLINE]
6.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

PMID:
18547499
[PubMed - indexed for MEDLINE]
Free Article
7.

Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides for gram-negative infections.

Destache CJ, Meyer SK, Padomek MT, Ortmeier BG.

DICP. 1989 Jan;23(1):33-8.

PMID:
2497587
[PubMed - indexed for MEDLINE]
8.

An evaluation of the clinical and cost-effectiveness of pulmonary artery catheters in patient management in intensive care: a systematic review and a randomised controlled trial.

Harvey S, Stevens K, Harrison D, Young D, Brampton W, McCabe C, Singer M, Rowan K.

Health Technol Assess. 2006 Aug;10(29):iii-iv, ix-xi, 1-133. Review.

PMID:
16904048
[PubMed - indexed for MEDLINE]
Free Article
9.

Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.

Kim MJ, Bertino JS Jr, Erb TA, Jenkins PL, Nafziger AN.

J Clin Pharmacol. 2004 Jul;44(7):696-707. Erratum in: J Clin Pharmacol. 2004 Sep;44(9):1072-4.

PMID:
15199074
[PubMed - indexed for MEDLINE]
10.

Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.

Koo J, Tight R, Rajkumar V, Hawa Z.

Am J Med. 1996 Aug;101(2):177-83.

PMID:
8757358
[PubMed - indexed for MEDLINE]
11.

Ethical dilemmas in a randomized trial of asthma treatment: can Bayesian statistical analysis explain the results?

Holley MT, Morrissey TK, Seaberg DC, Afessa B, Wears RL.

Acad Emerg Med. 2001 Dec;8(12):1128-35.

PMID:
11733289
[PubMed - indexed for MEDLINE]
12.

Aminoglycoside monitoring: use of a pharmacokinetic service versus physician recommendations.

Smith M, Murphy JE, Job ML, Ward ES.

Hosp Formul. 1987 Jan;22(1):92-9, 102.

PMID:
10280287
[PubMed - indexed for MEDLINE]
13.

Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.

Sveska KJ, Roffe BD, Solomon DK, Hoffmann RP.

Am J Hosp Pharm. 1985 Nov;42(11):2472-8.

PMID:
4073064
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

Bartal C, Danon A, Schlaeffer F, Reisenberg K, Alkan M, Smoliakov R, Sidi A, Almog Y.

Am J Med. 2003 Feb 15;114(3):194-8.

PMID:
12637133
[PubMed - indexed for MEDLINE]
15.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
16.

Aminoglycoside dosing: a randomized prospective study.

Kemme DJ, Daniel CI.

South Med J. 1993 Jan;86(1):46-51.

PMID:
8420016
[PubMed - indexed for MEDLINE]
17.

Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.

Garrelts JC.

Pharmacotherapy. 1996 Mar-Apr;16(2):286-94.

PMID:
8820474
[PubMed - indexed for MEDLINE]
18.

Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens.

Duffull SB, Kirkpatrick CM, Begg EJ.

Br J Clin Pharmacol. 1997 Feb;43(2):125-35.

PMID:
9131944
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Management of brain-injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges.

Fakhry SM, Trask AL, Waller MA, Watts DD; IRTC Neurotrauma Task Force.

J Trauma. 2004 Mar;56(3):492-9; discussion 499-500.

PMID:
15128118
[PubMed - indexed for MEDLINE]
20.

Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.

Mathews A, Bailie GR.

J Clin Pharm Ther. 1987 Oct;12(5):273-91. Review.

PMID:
3119606
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk